(Reuters) - The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.
The approval comes as generic drugmakers scramble to get their versions to the market and AstraZeneca is taken to court over so-called "pay-for-delay" settlements to delay the launch of generics to protect its drug's exclusivity.
14:35 Kim Zolciak Gets 'Cellulite Dimples' Injected With Filler — Watch The NSFW Procedure HERE!15
12:23 Lockheed Martin's quarterly profit handily beats estimates13
11:46 GM reports record 3Q earnings despite slowing US sales8
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents14